Department of Obstetrics and Gynecology, University of Campinas, Campinas, Brazil.
Contraception. 2011 Nov;84(5):e31-7. doi: 10.1016/j.contraception.2011.06.012. Epub 2011 Aug 10.
One of the well-established effects of the use of depot medroxyprogesterone acetate (DMPA) contraception is on bone mineral density (BMD). However, little evidence assesses the skeletal impact of long-term DMPA use. The objective of this study was to assess BMD on a cohort of women who used DMPA uninterruptedly between 1 and 15 years.
A cross-sectional study with 232 users of DMPA matched to a group of 232 copper intrauterine device (IUD) users by age (±1) (range 20-53 and 20-51 years for DMPA and IUD group, respectively), body mass index (BMI; kg/m(2)) (±1) (range 17.4-44.5 and 18.5-40.2 for DMPA and IUD group, respectively) and years of use (1-15 years) was performed. The women underwent forearm BMD evaluation using dual-energy X-ray absorptiometry. The women were divided into five groups (1-5) according to the length of DMPA use: 1-3, 4-6, 7-9, 10-12 and 13-15 years of use.
The mean (±SEM) age was 38.3±0.5 and 38.1±0.57 years and the mean (±SEM) BMI (kg/m(2)) was 26.4±0.3 and 26.3±0.3 for the entire group of women in the DMPA and IUD group, respectively. Women who used DMPA or IUD for a short time were younger and had lower BMI (kg/m(2)) than the women who used either contraceptive method long term. White women were significantly more frequent among IUD users (p<.040) than DMPA users. In addition, parity (p<.053) and physical activity (p<.012) were significantly greater among IUD users, whereas the prevalence of washing clothes by hand (p<.025) was significantly greater among DMPA users. There was no significant difference in BMD measurements between the current users of DMPA and those who had used the IUD either at the distal or ultra-distal sections of the forearm. However, women who had used DMPA for 13-15 years showed significantly lower BMD at the distal and ultra-distal radius when compared to IUD users (p<.041 and .042, respectively). Otherwise, all other differences in BMD values between DMPA and IUD users were nonsignificant at the distal and ultra-distal radius. For both DMPA and IUD users, we noted a direct correlation between higher BMD and BMI (kg/m(2)) and an inverse correlation between BMD and age for distal and ultra-distal radius.
Our study did not detect a deleterious effect on measurements of forearm BMD among long-term DMPA users with less than 13 years of use; however, a significantly lower BMD was observed at 13-15 years of use in DMPA users when compared to IUD users. Bone mineral density was inversely correlated to older age and directly correlated to BMI (kg/m(2)).
使用长效醋酸甲羟孕酮(DMPA)避孕的一个已确立的影响之一是对骨密度(BMD)的影响。然而,很少有证据评估长期使用 DMPA 对骨骼的影响。本研究的目的是评估一组连续使用 DMPA1 至 15 年的女性的 BMD。
这是一项横断面研究,共纳入 232 名连续使用 DMPA 的使用者,并按照年龄(±1 岁)(DMPA 和 IUD 组分别为 20-53 岁和 20-51 岁)、体重指数(BMI;kg/m²)(±1 岁)(DMPA 和 IUD 组分别为 17.4-44.5 岁和 18.5-40.2 岁)和使用年限(1-15 年)与 232 名铜宫内节育器(IUD)使用者相匹配。使用双能 X 射线吸收法评估前臂 BMD。根据 DMPA 使用年限将女性分为五组(1-5):1-3 年、4-6 年、7-9 年、10-12 年和 13-15 年。
DMPA 和 IUD 组女性的平均年龄(±SEM)分别为 38.3±0.5 岁和 38.1±0.57 岁,平均(±SEM)BMI(kg/m²)分别为 26.4±0.3 和 26.3±0.3。DMPA 和 IUD 组中短期使用 DMPA 或 IUD 的女性比长期使用这两种避孕方法的女性更年轻,BMI(kg/m²)更低。白人女性在 IUD 使用者中明显更为常见(p<.040),而 DMPA 使用者中则相反。此外,IUD 使用者的产次(p<.053)和体力活动(p<.012)明显更高,而 DMPA 使用者中手洗衣服的比例(p<.025)明显更高。当前 DMPA 使用者和那些曾在远端或超远端前臂使用 IUD 的使用者之间的 BMD 测量值没有显著差异。然而,与 IUD 使用者相比,使用 DMPA 13-15 年的女性在远端和超远端桡骨处的 BMD 明显较低(分别为 p<.041 和.042)。否则,DMPA 和 IUD 使用者在远端和超远端桡骨处的所有其他 BMD 值差异均无统计学意义。对于 DMPA 和 IUD 使用者,我们都发现 BMD 与 BMI(kg/m²)呈正相关,与年龄呈负相关,而在远端和超远端桡骨处,BMD 与年龄呈负相关。
我们的研究没有发现使用 DMPA 不足 13 年的长期使用者前臂 BMD 测量值有不良影响;然而,与 IUD 使用者相比,DMPA 使用者在使用 13-15 年时的 BMD 明显较低。骨密度与年龄呈负相关,与 BMI(kg/m²)呈正相关。